Skip to main content

Advertisement

Log in

Characterization of dopaminergic dysfunction in familial progressive supranuclear palsy: an 18F-dopa PET study

  • Short Communication
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary.

We analyzed 18F-dopa PET data from 11 members of kindreds with familial progressive supranuclear palsy (PSP) to characterize their cerebral dopaminergic dysfunction. Three clinically-affected PSP patients showed reduced 18F-dopa uptake in the striatum, orbitofrontal cortex and amygdala. One asymptomatic subject exhibited progressive putamen dopaminergic dysfunction. 60% of subjects with abnormal 18F-dopa scans developed PSP subsequently. This is the first in vivo documentation of cortical dopaminergic deficiency in PSP. Reduced striatal 18F-dopa uptake in susceptible relatives may predict later clinical disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Brooks DJ (1994) PET studies in progressive supranuclear palsy. J Neural Transm [Suppl 42]: 119–134

  • J Brown P Lantos M Stratton P Roques M Rossor (1993) ArticleTitleFamilial progressive supranuclear palsy J Neurol Neurosurg Psychiatry 56 473–476 Occurrence Handle8505637 Occurrence Handle1:STN:280:ByyB1c%2FlvV0%3D Occurrence Handle10.1136/jnnp.56.5.473

    Article  PubMed  CAS  Google Scholar 

  • G Chinaglia FJ Alvarez A Probst JM Palacios (1992) ArticleTitleMesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson’s disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H]mazindol Neuroscience 49 317–327 Occurrence Handle1436470 Occurrence Handle10.1016/0306-4522(92)90099-N Occurrence Handle1:STN:280:ByyD28zot1Q%3D

    Article  PubMed  CAS  Google Scholar 

  • Y Higuchi T Iwaki J Tateishi (1995) ArticleTitleNeurodegeneration in the limbic and paralimbic system in progressive supranuclear palsy Neuropathol Appl Neurobiol 21 246–254 Occurrence Handle7477733 Occurrence Handle1:STN:280:BymD2MbmtVI%3D Occurrence Handle10.1111/j.1365-2990.1995.tb01056.x

    Article  PubMed  CAS  Google Scholar 

  • NL Khan DJ Brooks N Pavese MG Sweeney NW Wood AJ Lees P Piccini (2002) ArticleTitleProgression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study Brain 125 2248–2256 Occurrence Handle12244082 Occurrence Handle10.1093/brain/awf237

    Article  PubMed  Google Scholar 

  • I Litvan Y Agid D Calne G Campbell B Dubois RC Duvoisin CG Goetz LI Golbe J Grafman JH Growdon M Hallett J Jankovic NP Quinn E Tolosa DS Zee (1996) ArticleTitleClinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop Neurology 47 1–9 Occurrence Handle8710059 Occurrence Handle1:STN:280:BymB1M7gtVI%3D

    PubMed  CAS  Google Scholar 

  • CS Patlak RG Blasberg (1985) ArticleTitleGraphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations J Cereb Blood Flow Metab 5 584–590 Occurrence Handle4055928 Occurrence Handle1:STN:280:BimD3svit10%3D

    PubMed  CAS  Google Scholar 

  • P Piccini J de Yebenez AJ Lees R Ceravolo N Turjanski P Pramstaller DJ Brooks (2001) ArticleTitleFamilial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography Arch Neurol 58 1846–1851 Occurrence Handle11708994 Occurrence Handle10.1001/archneur.58.11.1846 Occurrence Handle1:STN:280:DC%2BD3MnosFylsg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • W Pirker S Djamshidian S Asenbaum W Gerschlager G Tribl M Hoffmann T Brucke (2002) ArticleTitleProgression of dopaminergic degeneration in Parkinson’s disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study Mov Disord 17 45–53 Occurrence Handle11835438 Occurrence Handle10.1002/mds.1265

    Article  PubMed  Google Scholar 

  • A Rojo RS Pernaute A Fontan PG Ruiz J Honnorat T Lynch S Chin I Gonzalo A Rabano A Martinez S Daniel P Pramstaller H Morris N Wood A Lees C Tabernero T Nyggard AC Jackson A Hanson JG de Yebenes P Pramsteller (1999) ArticleTitleClinical genetics of familial progressive supranuclear palsy Brain 122 1233–1245 Occurrence Handle10388790 Occurrence Handle10.1093/brain/122.7.1233

    Article  PubMed  Google Scholar 

  • R Ros P Gomez Garre M Hirano YF Tai I Ampuero L Vidal A Rojo A Fontan A Vazquez S Fanjul J Hernandez S Cantarero J Hoenicka A Jones RL Ahsan N Pavese P Piccini DJ Brooks J Perez-Tur T Nyggard JG de Yebenes (2005) ArticleTitleGenetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1 Ann Neurol 57 634–641 Occurrence Handle15852377 Occurrence Handle10.1002/ana.20449 Occurrence Handle1:CAS:528:DC%2BD2MXkvFyktrY%3D

    Article  PubMed  CAS  Google Scholar 

  • JC Steele JC Richardson J Olszewski (1964) ArticleTitleProgressive Supranuclear Palsy Arch Neurol 10 333–359 Occurrence Handle14107684 Occurrence Handle1:STN:280:CCuD28rjslI%3D

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tai, Y., Ahsan, R., de Yébenes, J. et al. Characterization of dopaminergic dysfunction in familial progressive supranuclear palsy: an 18F-dopa PET study. J Neural Transm 114, 337–340 (2007). https://doi.org/10.1007/s00702-006-0536-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-006-0536-0

Keywords

Navigation